U.S. Soccer Stalls On NASL Decision A's Kaval Hosts "Office Hours" With Fans Kings, Sacramento Spar Over KJ Jersey New Documentaries On Olympic Channel NASCAR, Monster Energy Execs Meeting Minor Leaguers' Recovery Studied Intercollegiate Athletics Forum Starts Today SEC Title Game Audience Down MLB Distributes $77M In Playoff Pay A-B InBev's Busch Brand Gets Super Bowl Ad
SBD/5/Sponsorships Advertising Marketing
ONE MAN'S PAIN .... LEADS TO DAVIS INKING DEAL FOR MIGRAINES
Published February 5, 1998
Super Bowl XXXII MVP Terrell Davis has signed a multiyear deal with Novartis Pharmaceuticals to be its spokesperson and to raise awareness for Migranal, a new migraine treatment, according to Adam Schefter of the DENVER POST. Migranal is the same nasal spray Davis used to treat his migraine during the Super Bowl. Davis and Novartis will also partner to form the "Terrell Davis Foundation for Migraine Education and Treatment" (DENVER POST, 2/5). Davis' deal with Novartis garnered front-page attention in the BOSTON GLOBE where Larry Tye reports it is worth "several hundred thousand dollars a year." Davis: "I'm not putting my John Hancock on something I'm not truly behind." Part of what made the deal "attractive" to Davis is the agreement that each time he scores a touchdown next season, he and Novartis will both contribute money to the new foundation on migraine research (BOSTON GLOBE, 2/5).